TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line
Xiaohong Deng, Louise Fogh, Ulrik Axel Lademann, Vibeke Jensen, Jan Stenvang, Huanming Yang, Nils Brünner, Anne-Sofie Schrohl Rasmussen
3Citations
(Scopus)
Fingerprint
Dive into the research topics of 'TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line'. Together they form a unique fingerprint.